Back to Results
First PageMeta Content
Pharmaceutical sciences / Evaluation methods / Pharmaceutical industry / Clinical Data Management / Clinical trial / Electronic patient-reported outcome / Named patient programs / Clinical research / Research / Pharmacology


Document Date: 2013-07-21 06:37:48

Open Document

File Size: 988,77 KB

Share Result on Facebook

Company

Eli Lilly and Company / Wellcome Trust / Twitter / UCB Pharma / /

Country

Estonia / United Kingdom / /

Event

Person Communication and Meetings / /

Facility

Neil Weir / /

IndustryTerm

divergent / healthcare / pharmaceutical / case law / withdrawn products / healthcare priorities / unsuccessful applications / elegant solution / healthcare spectrum / /

MedicalCondition

rare diseases / disease / HIV/ AIDS / diseases / metabolic disease / /

Organization

European Union Agency / EFPIA's Scientific / Regulatory and Manufacturing Policy Committee / London School of Hygiene and Tropical Medicine / office of the European Ombudsman / Draft Agency / European Medicines Agency / Eichler / Vice / Nordic Cochrane Centre / European Union / An / European Rare Disease Organisation / /

Person

Ben Goldacre / Mark Walport / Peter Gøtzsche / Guido Rasi / Susan Forda / Buttarelli / Virginia Barbour / François Houÿez / Nada Photography / Hans-Georg Eichler / /

Position

President of Discovery / Executive Director / healthcare commentator in the UK / Supervisor and a representative / Health Policy officer / Senior Medical Officer / President / International Regulatory Affairs / Data Protection Supervisor / Supervisor / Director / way forward / data and transparency Workshop report Director / Chief Editor / Chair / representative / Assistant / judge / /

PublishedMedium

PLoS Medicine / /

URL

www.ema.europa.eu / /

SocialTag